IL95057A - Recombinant gene coding for a protein possessing urate oxidase activity - Google Patents
Recombinant gene coding for a protein possessing urate oxidase activityInfo
- Publication number
- IL95057A IL95057A IL95057A IL9505790A IL95057A IL 95057 A IL95057 A IL 95057A IL 95057 A IL95057 A IL 95057A IL 9505790 A IL9505790 A IL 9505790A IL 95057 A IL95057 A IL 95057A
- Authority
- IL
- Israel
- Prior art keywords
- oxidase activity
- gene coding
- urate oxidase
- recombinant gene
- protein possessing
- Prior art date
Links
- 108010092464 Urate Oxidase Proteins 0.000 title abstract 2
- 229940005267 urate oxidase Drugs 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title 2
- 102000004169 proteins and genes Human genes 0.000 title 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 229930182817 methionine Natural products 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0044—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7)
- C12N9/0046—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on other nitrogen compounds as donors (1.7) with oxygen as acceptor (1.7.3)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Superconductors And Manufacturing Methods Therefor (AREA)
- Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
- Glass Compositions (AREA)
- Saccharide Compounds (AREA)
Abstract
A recombinant protein possessing a specific urate oxidase activity of at least 16 U/mg and having the following sequence: preceded, if appropriate, by a methionine.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8909550A FR2649720A1 (en) | 1989-07-13 | 1989-07-13 | Recombinant gene which encodes a protein such as urate oxidase |
| FR8917466A FR2656530B1 (en) | 1989-12-29 | 1989-12-29 | RECOMBINANT GENE FOR EXPRESSION IN EUKARYOTIC CELLS OF A PROTEIN SUCH AS URATE OXIDASE. |
| FR9001368A FR2657785A2 (en) | 1989-12-29 | 1990-02-06 | Recombinant gene for expression of a protein such as urate oxidase in animal cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL95057A0 IL95057A0 (en) | 1991-06-10 |
| IL95057A true IL95057A (en) | 1997-07-13 |
Family
ID=27251947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL95057A IL95057A (en) | 1989-07-13 | 1990-07-12 | Recombinant gene coding for a protein possessing urate oxidase activity |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0408461B1 (en) |
| JP (1) | JP2664804B2 (en) |
| AT (1) | ATE144282T1 (en) |
| AU (1) | AU636637B2 (en) |
| BR (1) | BR9006855A (en) |
| CA (1) | CA2035900C (en) |
| DE (2) | DE10199042I2 (en) |
| DK (1) | DK0408461T3 (en) |
| ES (1) | ES2095243T3 (en) |
| FI (1) | FI105047B (en) |
| GR (1) | GR3022085T3 (en) |
| HU (1) | HU215948B (en) |
| IE (1) | IE77158B1 (en) |
| IL (1) | IL95057A (en) |
| LU (1) | LU90781I2 (en) |
| LV (1) | LV12000B (en) |
| MC (1) | MC2145A1 (en) |
| NL (1) | NL300046I2 (en) |
| NO (1) | NO2001018I2 (en) |
| NZ (1) | NZ234453A (en) |
| PT (1) | PT94680B (en) |
| RU (1) | RU2105812C1 (en) |
| WO (1) | WO1991000909A1 (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2971218B2 (en) * | 1991-12-04 | 1999-11-02 | 協和醗酵工業株式会社 | Uricase gene and method for producing uricase |
| US5691188A (en) | 1994-02-14 | 1997-11-25 | American Cyanamid Company | Transformed yeast cells expressing heterologous G-protein coupled receptor |
| US6083725A (en) | 1996-09-13 | 2000-07-04 | Transkaryotic Therapies, Inc. | Tranfected human cells expressing human α-galactosidase A protein |
| PL190041B1 (en) * | 1996-09-13 | 2005-10-31 | Transkaryotic Therapies | Therapy against alpha-galactosidase a deficiency |
| PT2158923E (en) | 1998-08-06 | 2013-06-04 | Univ Duke | Peg-urate oxidase conjugates and use thereof |
| RU2278680C2 (en) * | 1998-08-06 | 2006-06-27 | Маунтэн Вью Фармасьютикэлз, Инк. | Method for isolation of tetra-dimensional form of uricase and uricase |
| US6783965B1 (en) * | 2000-02-10 | 2004-08-31 | Mountain View Pharmaceuticals, Inc. | Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| EP1310560A4 (en) | 2000-08-17 | 2005-07-13 | Ajinomoto Kk | Method of modifying microorganism-origin transglutaminase |
| DK1503788T3 (en) | 2002-04-25 | 2011-10-17 | Shire Human Genetic Therapies | Treatment of alpha-galactosidase A deficiency |
| ES2538357T3 (en) | 2005-04-11 | 2015-06-19 | Crealta Pharmaceuticals Llc | Variant forms of urate oxidase and use thereof |
| US8148123B2 (en) | 2005-04-11 | 2012-04-03 | Savient Pharmaceuticals, Inc. | Methods for lowering elevated uric acid levels using intravenous injections of PEG-uricase |
| CA2604545A1 (en) | 2005-04-11 | 2006-10-19 | Savient Pharmaceuticals, Inc. | A variant form of urate oxidase and use thereof |
| TWI418564B (en) * | 2005-04-11 | 2013-12-11 | Savient Pharmaceuticals Inc | Purification of proteins with cationic surfactant |
| EP2013225B1 (en) * | 2006-04-12 | 2014-12-17 | Crealta Pharmaceuticals LLC | Purification of proteins with cationic surfactant |
| RU2443426C2 (en) * | 2008-11-07 | 2012-02-27 | Мунтэн Вью Фармасьютикэлз, Инк. | Urate oxidase conjugates, pharmaceutical composition for reduction in uric acid levels and method for preparing conjugates stated above |
| US9377454B2 (en) | 2009-06-25 | 2016-06-28 | Crealta Pharmaceuticals Llc | Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy |
| JP2019535819A (en) | 2016-11-11 | 2019-12-12 | ホライゾン ファーマ リューマトロジー リミテッド ライアビリティ カンパニーHorizon Pharma Rheumatology Llc | Combination therapy and use of prednisone and uricase molecules |
| CN109223707B (en) * | 2018-09-13 | 2020-12-08 | 中国药科大学 | A kind of uricase gel preparation for external use, its preparation method and use |
| WO2020160325A1 (en) | 2019-01-30 | 2020-08-06 | Horizon Pharma Rheumatology Llc | Reducing immunogenicity to pegloticase |
| US12269875B2 (en) | 2023-08-03 | 2025-04-08 | Jeff R. Peterson | Gout flare prevention methods using IL-1BETA blockers |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1529675A (en) * | 1967-03-29 | 1968-06-21 | Applic Biochimiques Soc Et | High activity urate oxidase and its preparation |
| SU457723A1 (en) * | 1973-04-09 | 1977-08-05 | Всесоюзный Научно-Исследовательский Витаминный Институт | Strain 313-152 actinomyces sp.as producer of uratoxydase |
| CA1341130C (en) * | 1984-07-27 | 2000-10-31 | Adrianus Marinus Ledeboer | Use of oxidoreductases in bleaching and/or detergent compositions and their preparation by microorganisms engineered by recombinant dna technology |
| WO1988008450A1 (en) * | 1987-05-01 | 1988-11-03 | Birdwell Finlayson | Gene therapy for metabolite disorders |
| JPH0671428B2 (en) * | 1988-08-17 | 1994-09-14 | サッポロビール株式会社 | Uricase DNA sequence and process |
-
1990
- 1990-07-11 NZ NZ234453A patent/NZ234453A/en unknown
- 1990-07-12 PT PT94680A patent/PT94680B/en not_active IP Right Cessation
- 1990-07-12 IL IL95057A patent/IL95057A/en active IP Right Grant
- 1990-07-13 AU AU60523/90A patent/AU636637B2/en not_active Expired
- 1990-07-13 AT AT90402023T patent/ATE144282T1/en active
- 1990-07-13 DK DK90402023.7T patent/DK0408461T3/en active
- 1990-07-13 RU SU4895030/13A patent/RU2105812C1/en active
- 1990-07-13 WO PCT/FR1990/000532 patent/WO1991000909A1/en not_active Ceased
- 1990-07-13 CA CA002035900A patent/CA2035900C/en not_active Expired - Lifetime
- 1990-07-13 EP EP90402023A patent/EP0408461B1/en not_active Expired - Lifetime
- 1990-07-13 ES ES90402023T patent/ES2095243T3/en not_active Expired - Lifetime
- 1990-07-13 IE IE255990A patent/IE77158B1/en not_active IP Right Cessation
- 1990-07-13 BR BR909006855A patent/BR9006855A/en not_active Application Discontinuation
- 1990-07-13 MC MC@@@@D patent/MC2145A1/en unknown
- 1990-07-13 DE DE2001199042 patent/DE10199042I2/en active Active
- 1990-07-13 DE DE69028884T patent/DE69028884T2/en not_active Expired - Lifetime
- 1990-07-13 HU HU906046A patent/HU215948B/en active Protection Beyond IP Right Term
- 1990-07-13 JP JP2510514A patent/JP2664804B2/en not_active Expired - Lifetime
-
1991
- 1991-03-12 FI FI911212A patent/FI105047B/en active Protection Beyond IP Right Term
-
1996
- 1996-12-18 GR GR960403531T patent/GR3022085T3/en unknown
-
1997
- 1997-10-15 LV LVP-97-200A patent/LV12000B/en unknown
-
2001
- 2001-05-23 LU LU90781C patent/LU90781I2/en unknown
- 2001-06-12 NL NL300046C patent/NL300046I2/en unknown
- 2001-10-30 NO NO2001018C patent/NO2001018I2/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL95057A (en) | Recombinant gene coding for a protein possessing urate oxidase activity | |
| AU1235392A (en) | Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof | |
| ES8704976A1 (en) | A novel human physiologically active polypeptide. | |
| KR0180256B1 (en) | Bpc peptides, their preparation and use | |
| AU4614689A (en) | A gene and gene structure coding for an aminotransferase, and microorganisms which express this gene | |
| DE69230535D1 (en) | Polyphenol oxidase gene | |
| GR3002480T3 (en) | Condom | |
| AU1384688A (en) | 1,5-substituted 1H-imidazoles | |
| AU5372690A (en) | Genes coding for a protein having human macif activity, expression vectors containing said genes, transformant cells and proteins having human macif activity | |
| AU3979989A (en) | Dna encoding human monoamine oxidase type a | |
| IL76194A (en) | 4,5-dihydro-4-oxo-2-((2-trans-phenyl cyclopropyl)amino)-3-furancarboxylic acids and derivatives | |
| AU2280192A (en) | Recombinant dna coding for a protein with endochitinase activity | |
| AU6910991A (en) | The scl gene, and the encoded hematopoietic factor | |
| CA2066263A1 (en) | Tsh receptor | |
| AU591892B2 (en) | Peptides | |
| AU1902088A (en) | Tertiary 2,5-dialkyl-3-phenylpiperidine derivatives having opiate-antagonistic activity | |
| IL89241A (en) | Recombinant vector comprising a dna segment encoding an enzyme having 2,5-diketogluconic acid(2,5-dkg)reductase activity | |
| AU5627090A (en) | A novel alpha-amylase-pullulanase enzyme, a dna sequence coding the same, a recombinant dna molecule and a recombinant clone expressing the enzyme | |
| AU6403590A (en) | Isolated, physiologically active human thrombomodulin polypeptide | |
| CA2067176A1 (en) | Recombinant gene coding for a protein having an endochitinase activity | |
| BG102479A (en) | Mew peptides, method for their preparation and application | |
| EP0222726A3 (en) | Mutant coding sequence | |
| AU5239290A (en) | Purification of c.pseudotuberculosis toxin, and cloning and expression of toxin gene | |
| GB2199830B (en) | Recombinant plasmid dna pvn22, coding for biosynthesis of human leukocyte interferon -i1 and strain pseudomonas sp. 31 (pvn22) | |
| AU589447B2 (en) | Process and intermediates for antiarrhythmic 1,3- diazabicyclo(4.4.0) dec-2-en-4-ones |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| HC | Change of name of proprietor(s) | ||
| KB | Patent renewed |